$ROIV Cashflow Statement | Understand Stock

$ROIV

$36.54 +$0.49 (1.36%) Close

$ROIV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Mar 31, 2026	FY2024 12 months to Mar 31, 2025	FY2023 12 months to Mar 31, 2024	FY2022 12 months to Mar 31, 2023	FY2021 12 months to Mar 31, 2022
Cash flows from operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Non-cash acquired in-process research and development
Share-based compensation
Change in fair value of investments
Gain on sale of investment
Change in fair value of debt and liability instruments
Gain on deconsolidation of subsidiary and consolidation of unconsolidated entity
Gain on sale of subsidiary interests
Gain on deconsolidation of subsidiaries
Gain on termination of Sumitomo Options
Loss from equity method investment
Gain on sale of Telavant net assets
Gain on recovery of contingent consideration
Impairment loss on operating lease right-of-use assets
Accretion of discount and amortization of premium on available-for-sale marketable securities, net
Accretion of discount and amortization of premium on held-to-maturity marketable securities, net
Realized gain from sales of marketable securities
Loss on extinguishment of debt
Depreciation and amortization
Non-cash lease expense
Other

Changes in assets and liabilities, net of effects from acquisition and divestiture:
Other current assets
Other assets
Litigation settlement receivable
Accounts payable
Accrued expenses
Deferred consideration liability
Deferred revenue
Operating lease liabilities
Other
Accrued interest
Income tax payable
Other liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of marketable securities
Maturities of marketable securities
Marketable securities, available-for-sale
Purchases
Proceeds from maturities
Proceeds from sales
Marketable securities, held-to-maturity
Purchases
Proceeds from maturities
Proceeds from sale of Telavant net assets, net
Proceeds from sale of subsidiary interests
Cash decrease upon deconsolidation of subsidiaries
Proceeds from sale of investment
Proceeds from sale of Myovant Top-Up Shares
Milestone payments
Purchase of property and equipment
Other
Net cash (used in) provided by investing activities

Cash flows from financing activities:
Repurchase of the Company’s common shares
Parent Company
Subsidiaries
Total repurchase of the Company’s common shares
Proceeds from issuance of the Company’s common shares, net of issuance costs paid
Proceeds from Business Combination and PIPE Financing
Proceeds from payment of subscription receivable
Proceeds from subsidiary debt financings, net of financing costs paid
Proceeds from issuance of subsidiary common shares, net of issuance costs paid
Repayment of debt by subsidiary
Payment of offering costs and loan origination costs
Contribution from minority interest holder to subsidiary
Proceeds from exercise of the Company’s and subsidiary stock options
Taxes paid related to net settlement of equity awards
Proceeds from issuance of the Company’s common shares under employee stock purchase plan
Other
Payments on principal portion of finance lease obligations
Payment of subsidiary dividend
Proceeds from exercise of the Company’s warrants
Payment for redemptions of the Company’s warrants
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net change in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Non-cash investing and financing activities:
Subscription receivable related to issuance of subsidiary common shares
Cashless exercise of the Company’s warrants
Issuance of subsidiary shares in connection with debt renegotiation
Operating lease right-of-use assets obtained and exchanged for operating lease liabilities
Issuance of the Company's common shares and other consideration for an acquisition
Reclassification of earn-out shares liability to additional paid-in capital upon vesting
Taxes payable related to net settlement of equity awards
Other

Supplemental disclosure of cash paid:
Income taxes paid
Interest paid

Comments